A diverse portfolio of novel drug discovery efforts for Alzheimer's disease: Meeting report from the 11th International Conference on Alzheimer's Drug Discovery, 27-28 September 2010, Jersey City, NJ, USA

Linda H Lee; Diana W Shineman; Howard M Fillit

doi:10.1186/alzrt57

A diverse portfolio of novel drug discovery efforts for Alzheimer's disease: Meeting report from the 11th International Conference on Alzheimer's Drug Discovery, 27-28 September 2010, Jersey City, NJ, USA

Alzheimers Res Ther. 2010 Dec 15;2(6):33. doi: 10.1186/alzrt57.

Authors

Linda H Lee¹, Diana W Shineman, Howard M Fillit

Affiliation

¹ Center for Neurobiology and Behavior, Columbia University, 630 West 168th Street, P&S 12-510, New York, NY 10032, USA. LL2429@columbia.edu.

PMID: 21159211
PMCID: PMC3031879
DOI: 10.1186/alzrt57

Abstract

While Alzheimer's disease researchers continue to debate the underlying cause(s) of the disease, most agree that a diverse, multi-target approach to treatment will be necessary. To this end, the Alzheimer's Drug Discovery Foundation (ADDF) recently hosted the 11th International Conference on Alzheimer's Drug Discovery to highlight the array of exciting efforts from the ADDF's funded investigators.